Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation. - Wikidata - wikimedia - TriplyDB

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation.

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q37570624

about

Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.Allogeneic cell therapy manufacturing: process development technologies and facility design options.

P2860

Q47392381-07ACCF50-640D-465C-BBE4-E0E51F76F42C Q50432799-6C01AD8F-0795-42AD-A6DC-F3FB0555C819

P2860

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q37570624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term outcome following cy ...... tic stem cell transplantation.

@en

Long-term outcome following cy ...... tic stem cell transplantation.

@nl

type

label

Long-term outcome following cy ...... tic stem cell transplantation.

@en

Long-term outcome following cy ...... tic stem cell transplantation.

@nl

prefLabel

Long-term outcome following cy ...... tic stem cell transplantation.

@en

Long-term outcome following cy ...... tic stem cell transplantation.

@nl

P1433

Q37570624-41B593C3-58B7-421B-8BC2-933A10F863D5

P1476

Q37570624-D2144914-C3FB-45D2-9826-4326A08EEBFD

P2093

Q37570624-07DD883C-ACEC-40F2-9D08-95DABA72BF00

Q37570624-3818002C-C8BB-4A2B-83B1-B0182B8A1C38

Q37570624-593E4D37-C39F-403A-B695-0878F80C681E

Q37570624-8B82BD93-709A-40DC-9B3C-4CACC597B45E

Q37570624-9C45C3FB-1F15-4D5E-994E-3A1121EFC9D4

Q37570624-9E0F695D-8150-47CE-BF6B-5805866F610D

Q37570624-9F7C7323-D3A7-4BB6-812D-D01A50CD6B77

Q37570624-B52979E5-C5F8-4CFF-A579-F1FB7C259C48

Q37570624-D27F10D7-91F1-4B28-9F5B-007752110792

P2860

Q37570624-01A037DF-9FEA-4D9A-B357-C4C25BE109FF

Q37570624-105E114B-B88F-41CA-BCED-EA1C80DA29FF

Q37570624-11F2056D-BF2F-47B8-ADCA-C160A485CBCD

Q37570624-144FDCAB-EF88-43D8-8720-0FFDAF201C8F

Q37570624-2EFD85C4-CF46-48B3-8F2D-B478879CEEB7

Q37570624-36E34BA6-C9AD-461B-8590-368DE216420C

Q37570624-384D0F58-A731-42FA-B4BF-C9CE6EA3917B

Q37570624-442BCC48-2D56-4B1C-A4F6-55DB4AA63C7A

Q37570624-4CF10B34-FDBC-4ACC-9E4B-0C784FA31935

Q37570624-8830D21C-7993-4339-AA29-CA5DD1E37C01

P2888

Q37570624-2556C3CB-1AF2-4159-B7C2-8BB228724FE9

P304

Q37570624-18BF572B-8DBE-4A44-BF07-AF681F696A77

P31

Q37570624-BE254D8F-6C29-42EB-B467-129524F154A0

P356

Q37570624-31F15553-E3A7-4776-B21A-1E77F0EFD746

P407

Q37570624-138FA9F8-8B45-4FA2-9755-86A12101BB4E

P433

Q37570624-6A85C7F5-1542-4013-B443-D4409971F33D

P478

Q37570624-5CC23ED8-4FA5-4E76-9EBE-C00D11730DDF

P577

Q37570624-179A4F6C-0478-4896-AFF2-DF0108A1259E

P698

Q37570624-B4872EEE-AF45-4336-8E5E-1EE336304CFC

P921

Q37570624-536C84B4-342F-47ED-A401-CAFE18745888

P932

Q37570624-C207B605-5695-4BCE-AAB8-389D78175615

P356

P1433

Bone Marrow Transplantation

P1476

Long-term outcome following cy ...... tic stem cell transplantation.

@en

P2093

J Silva

http://www.w3.org/2001/XMLSchema#string

K Rao

http://www.w3.org/2001/XMLSchema#string

K Straathof

http://www.w3.org/2001/XMLSchema#string

O Nikolajeva

http://www.w3.org/2001/XMLSchema#string

P Anoop

http://www.w3.org/2001/XMLSchema#string

P J Amrolia

http://www.w3.org/2001/XMLSchema#string

P Veys

http://www.w3.org/2001/XMLSchema#string

R Chiesa

http://www.w3.org/2001/XMLSchema#string

Z Allwood

http://www.w3.org/2001/XMLSchema#string

P2860

PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation

A reversible posterior leukoencephalopathy syndrome

High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome

Neurotoxicity of calcineurin inhibitors: impact and clinical management.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.

Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.

Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.

P2888

P304

159-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.232

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27643866

http://www.w3.org/2001/XMLSchema#string

P921

P932

5220133

http://www.w3.org/2001/XMLSchema#string